Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...
GlobalData on MSN1d
Perspectum awarded $250k FDA grant for rare disease researchThe grant will support Perspectum’s research into the development of a novel biomarker for primary sclerosing cholangitis ...
The U.S. Food and Drug Administration approved PTC Therapeutics, Inc.'s Kebilidi (eladocagene exuparvovec-tneq) gene therapy for the ...
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
Hiddo L. Heerspink got the idea for this study at the beginning of the corona pandemic. Earlier, he had discovered that another class of drugs against type 2 diabetes, the so-called SGLT2 ...
A new study has examined a large sample of privately ... patients corresponding to the rising use of blockbuster GLP-1 RA drugs," said senior author Thomas C. Tsai, MD, MPH, a metabolic bariatric ...
the lead author of a new study that looked at health records of 17 million privately insured Americans with obesity. It found that between 2022 and 2023, as prescriptions for GLP-1 drugs more than ...
Semaglutide medications — such as Ozempic, the popular diabetes drug — have been linked to a reduced risk of Alzheimer’s disease for certain groups. A new study, which was led by researchers ...
Marinus Pharmaceuticals' Oral Seizure Drug Disappoints In Late-Stage Study, Appoints Advisor To Explore Options Vandana Singh Thu, Oct 24, 2024, 12:42 PM 2 min read ...
The new Case Western study released Thursday builds on other research released in July on a once-daily drug for diabetes and obesity called liraglutide, which Novo Nordisk sells under the brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback